Tokyo Tape
Sign in
← OLBA Healthcare Holdings

Quarterly report · Q2

2689.TEDINET S100Q89E
Period2022-07-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥53.7bn2022-07-01 → 2022-12-31Cons.Net sales
Revenue¥108.0bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥53.0bn2021-07-01 → 2021-12-31Cons.Net sales
Operating income¥854m2022-07-01 → 2022-12-31Cons.Operating income
Operating income¥787m2021-07-01 → 2021-12-31Cons.Operating income
Ordinary income¥859m2022-07-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥2.1bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥803m2021-07-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥857m2022-07-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥783m2021-07-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥548m2022-07-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥533m2021-07-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥548m2022-07-01 → 2022-12-31Cons.Profit loss
Net income¥533m2021-07-01 → 2021-12-31Cons.Profit loss
Total assets¥40.6bnat 2022-12-31Cons.Assets
Total assets¥40.0bnat 2022-06-30Cons.Assets
Total assets¥41.6bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥31.3bnat 2022-12-31Cons.Liabilities
Total liabilities¥30.9bnat 2022-06-30Cons.Liabilities
Net assets / equity¥9.3bnat 2022-12-31Cons.Net assets
Net assets / equity¥9.1bnat 2022-06-30Cons.Net assets
Net assets / equity¥8.3bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥3.2bnat 2022-06-30Cons.Cash and deposits
Cash & equivalents¥2.6bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.1bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥3.1bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2021-06-30dCons.Cash and cash equivalents
Operating cash flow−¥1.9bn2022-07-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥2.4bn2021-07-01 → 2022-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥867m2021-07-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥143m2022-07-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥212m2021-07-01 → 2022-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥278m2021-07-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥1.5bn2022-07-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.2bn2021-07-01 → 2022-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.2bn2021-07-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥91.092022-07-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.242022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥252.82021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥87.572021-07-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.752021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio22.9%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio22.8%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio20.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-12-31−¥789m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-12-31−¥789m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-12-31−¥71m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue2022-07-01 → 2022-12-31¥1.2bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue external2022-07-01 → 2022-12-31¥1.2bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥104,000
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentsegment profit2022-07-01 → 2022-12-31¥92m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue2022-07-01 → 2022-12-31¥50.7bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue external2022-07-01 → 2022-12-31¥50.0bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥726m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentsegment profit2022-07-01 → 2022-12-31¥735m
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue2022-07-01 → 2022-12-31¥2.6bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue external2022-07-01 → 2022-12-31¥2.5bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥64m
jpcrp040300-q2r_E02928-000SPDreportable segmentsegment profit2022-07-01 → 2022-12-31¥98m
Total Of Reportable Segments And Otherssegment totalrevenue2022-07-01 → 2022-12-31¥54.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-07-01 → 2022-12-31¥53.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-07-01 → 2022-12-31¥789m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2022-12-31¥925m
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-12-31−¥674m
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-12-31−¥674m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-12-31−¥80m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue2021-07-01 → 2021-12-31¥1.2bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue external2021-07-01 → 2021-12-31¥1.2bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2021-07-01 → 2021-12-31¥257,000
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentsegment profit2021-07-01 → 2021-12-31¥85m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue2021-07-01 → 2021-12-31¥50.2bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue external2021-07-01 → 2021-12-31¥49.6bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2021-07-01 → 2021-12-31¥610m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentsegment profit2021-07-01 → 2021-12-31¥720m
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue2021-07-01 → 2021-12-31¥2.3bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue external2021-07-01 → 2021-12-31¥2.3bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue intersegment2021-07-01 → 2021-12-31¥63m
jpcrp040300-q2r_E02928-000SPDreportable segmentsegment profit2021-07-01 → 2021-12-31¥61m
Total Of Reportable Segments And Otherssegment totalrevenue2021-07-01 → 2021-12-31¥53.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-07-01 → 2021-12-31¥53.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-07-01 → 2021-12-31¥674m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-07-01 → 2021-12-31¥866m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 508
ItemContextValueUnit
Retained earningsPrior1YearInstant8369369000JPY
Retained earningsCurrentQuarterInstant8549905000JPY
Treasury stockPrior1YearInstant-375903000JPY
Treasury stockCurrentQuarterInstant-362555000JPY
Shareholders equityPrior1YearInstant8916919000JPY
Shareholders equityCurrentQuarterInstant9116633000JPY
Valuation difference on available for sale securitiesPrior1YearInstant121157000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant110085000JPY
Remeasurements of defined benefit plansPrior1YearInstant55229000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant50516000JPY
Valuation and translation adjustmentsPrior1YearInstant176387000JPY
Valuation and translation adjustmentsCurrentQuarterInstant160601000JPY
Non controlling interestsPrior1YearInstant－JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant9093306000JPY
Net assetsCurrentQuarterInstant9277235000JPY
Liabilities and net assetsPrior1YearInstant39968672000JPY
Liabilities and net assetsCurrentQuarterInstant40562264000JPY
Net salesPrior1YTDDuration53030262000JPY
Net salesCurrentYTDDuration53718093000JPY
Cost of salesPrior1YTDDuration47119022000JPY
Cost of salesCurrentYTDDuration47535917000JPY
Gross profitPrior1YTDDuration5911239000JPY
Gross profitCurrentYTDDuration6182175000JPY
Selling general and administrative expensesPrior1YTDDuration5124434000JPY
Selling general and administrative expensesCurrentYTDDuration5328089000JPY
Operating incomePrior1YTDDuration786804000JPY
Operating incomeCurrentYTDDuration854086000JPY
Interest income noiPrior1YTDDuration181000JPY
Interest income noiCurrentYTDDuration191000JPY
Dividends income noiPrior1YTDDuration768000JPY
Dividends income noiCurrentYTDDuration912000JPY
Insurance income noiPrior1YTDDuration7415000JPY
Insurance income noiCurrentYTDDuration376000JPY
Commission fee noiPrior1YTDDuration10337000JPY
Commission fee noiCurrentYTDDuration2495000JPY
Electricity sale income noiPrior1YTDDuration4201000JPY
Electricity sale income noiCurrentYTDDuration5087000JPY
Subsidy income noi bountyPrior1YTDDuration2335000JPY
Subsidy income noi bountyCurrentYTDDuration6320000JPY
Equity in earnings of affiliates noiPrior1YTDDuration3127000JPY
Equity in earnings of affiliates noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration3385000JPY
Other noiCurrentYTDDuration3042000JPY
Non operating incomePrior1YTDDuration31752000JPY
Non operating incomeCurrentYTDDuration18425000JPY
Interest expenses noePrior1YTDDuration10656000JPY
Interest expenses noeCurrentYTDDuration9222000JPY
Electricity sale expenses noePrior1YTDDuration2890000JPY
Electricity sale expenses noeCurrentYTDDuration2465000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-06-30pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-07-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-07-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-07-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass